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Objectives: The purpose of this study was to improve our understanding of the prevalence of acanthosis nigricans (AN) and its 
clinical relevance in our mixed-ancestry population and to investigate its association with abnormal glucose metabolism, obesity 
and hypertension.
Design: This was a cross-sectional study.
Settings and subjects: A total of 390 healthy mixed-ancestry females were recruited from the dermatology outpatient clinic at 
Tygerberg Hospital.
Outcomes measured: A short questionnaire was administered, whereafter participants were inspected for the presence and 
degree of AN. Height, weight, blood pressure and random fingerpick blood glucose were measured.
Results: AN was observed in 30% (n = 116) of participants, and most commonly found in the nape of the neck (94%, n = 109). 
Participants with AN were younger (p = 0.005), and of higher body mass (p < 0.001) with a higher random blood glucose (p = 
0.04). AN was more commonly seen in diabetics (p = 0.004). The presence and severity of AN in the neck correlated far better with 
BMI and blood glucose than other sites, including the axilla.
Conclusion: AN was found to be extremely common, with a prevalence of 30% in this group. An association with blood glucose 
levels, diabetes and obesity was demonstrated, proving that it is not just a normal ethnic phenomenon. No association with 
blood pressure or hypertension was found.
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Introduction
Acanthosis nigricans (AN) is characterised by a symmetrical, hyper-
pigmented velvety thickening of the skin that is usually confined 
to the flexural areas of the body, particularly the nape of the neck 
(> 90%) and the axillae.1,2
A number of studies have associated AN with malignancy,3 but 
mostly with insulin resistance, obesity, hyperinsulinaemia and an 
increased risk of developing type 2 diabetes mellitus (T2DM) in 
both paediatric and adult populations.4,5 Insulin signalling affects 
both metabolic as well as mitogenic pathways. Numerous defects 
in insulin signalling have been described, which may result in 
insulin resistance.6 It is conceptually attractive to propose that 
defects in the ‘metabolic’ limb of the signalling pathway, which lead 
to hyperglycaemia, hyperinsulinaemia and increased circulating 
IGF-1, result in activation of the intact ‘mitogenic’ pathway, with 
consequent overstimulation of mitogenesis in various organs 
including the ovaries (polycystic ovary syndrome, PCOS), endotheli-
al and vascular smooth muscle cells (atherosclerosis), as well as the 
skin (acanthosis nigricans).7 If this is the case, the presence of AN can 
potentially be put to clinical use as an easily identifiable marker of 
underlying insulin resistance and mitogenesis.
AN has been described as rare, but in selected patient groups the 
prevalence of this skin condition has reportedly ranged from 5% 
to 50%.4,5 This may be due to an increased prevalence of obesity 
and T2DM in these populations, but may also simply represent a 
normal phenotype. It is well established that AN has a significant 
ethnic predisposition, being rare among whites, but more 
common among Blacks and especially prevalent among Asians 
and individuals of mixed ancestry.2,4,5,8,9
Our clinical impression at the Tygerberg Academic Hospital is 
that AN is relatively common, especially in our patients of 
mixed ancestry, and that both diabetic and non-diabetic popu-
lations appear to be affected. We are not aware of any previous 
studies in South Africa looking at the prevalence and clinical 
significance of AN in diabetic and non-diabetic populations. If a 
clear association between T2DM and AN exists, the latter could 
be used as a marker of diabetes. However, if AN merely repre-
sents an ethnic phenomenon, over- investigation of patients 
with AN may lead to wasted resources and should be discour-
aged.
The proposed study was therefore undertaken to improve our 
understanding of the prevalence of AN and its clinical relevance 
in our mixed ancestry population and to investigate the extent 
to which the prevalence and severity of AN is related to 
abnormal glucose metabolism, obesity and hypertension.
Methods
This was a cross-sectional study of 390 healthy female patients of 
mixed ancestry attending the Dermatology Outpatient Clinic at 
Tygerberg Academic Hospital, Western Cape, South Africa, to 
determine the prevalence of AN. Sample size was calculated 
based on an estimated AN prevalence of up to 50%. The study 
was approved by the Health Research Ethics committee of 
Stellenbosch University, Cape Town, South Africa.
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The inclusion criteria included all females of mixed ancestry, aged 
30–70 years, seen consecutively at the clinic between 2012 and 2013, 
by a single observer (MH). Patients known to have malignancies, 
heavy alcohol use, known secondary diabetes or current systemic 
corticosteroid use were excluded. The single investigator (MH) was 
responsible for participant recruitment, obtaining informed consent, 
administration of a standardised questionnaire and clinical 
examination.
Mixed ancestry/Coloured describes a heterogeneous South African 
population group, with diverse ancestral links, which is the largest 
population group in the Western Cape. In this study, individuals were 
identified as being of mixed ancestry based on clinical perception, 
data capturing from identity documents, as well as self-classification 
by female patients attending the dermatology clinic.
Anthropometric measurements included weight, height and the 
calculation of body mass index (BMI). Weight was determined with a 
digital scale (Healthometer®, Sunbeam/Pelsar LLC, USA) and reported 
to the nearest 200 g. Height was recorded with a stadiometer and 
reported to the nearest centimetre, BMI was calculated as weight/
(height in metres)2 and expressed in kg/m2. An individual was 
categorised as either underweight (BMI < 18.5 kg/m2), normal weight 
(BMI 18.5–24.9  kg/m2), overweight (BMI 25–29.9  kg/m2) or obese 
(class I BMI 30–34.9 kg/m2, class II 35–39.9 kg/m2 and class III 40 kg/m2 
and above). A resting blood pressure was recorded in the sitting 
position with the Boso-medicus Uno automated blood pressure 
apparatus (Bosch and Sohn, Jungingen, Germany) and reported in 
mmHg. An obese cuff was used where indicated. An individual was 
classified as hypertensive if previously diagnosed, or with a systolic 
blood pressure above 140 mmHg or diastolic blood pressure above 
90 mmHg on the day of participation.
The presence and degree of AN was assessed using the Burke 
scale for AN.2 Five locations were examined (neck, axilla, elbows, 
knuckles and knees), with the severity in the neck and axilla 
graded on a scale of 0 to 4 (Table 1). This AN scale enables the 
reliable identification of AN with little inter-observer variability, 
with AN in the neck showing the least variability. In cases where 
the classification was difficult, a single specialist dermatologist 
(WIF) was consulted.
A random finger-prick blood glucose was performed with the Accu-
Check® Active (Roche, Mannheim, Germany) point of care testing 
device and reported in mmol/l. Glucose measurements were done 
on all participants after the skin inspection to prevent observer bias. 
In subjects without known diabetes, for the purposes of this 
particular study, a random blood glucose > 11.1 mmol/l was regarded 
as being compatible with diabetes and the participant was referred 
for appropriate further management. Those with a random 
glucose < 7.8 mmol/l were regarded as having normoglycaemia. A 
venous blood sample for haemoglobin A1C (HbA1C) was collected 
when the random blood glucose was between 7.8 and 11.1 mmol/l. 
Those individuals with HbA1C values of  ≥  6.5% were regarded as 
probably having diabetes.
Statistical analysis
Individuals were identified with a unique study number and 
only the primary investigator had access to identifying patient 
information. A single statistician (JH) from the Centre for Statistical 
Consultation of the University of Stellenbosch, blinded to the 
study population, analysed the data using STATISTICA® version 
10 of 2013 software (StatSoft Inc., Tulsa, OK, USA) and Excel® 
(Microsoft, Seattle, WA, USA). Descriptive statistics were used to 
analyse each parameter in terms of distribution, mean, median, 
quartiles, maximum and minimum values and standard 
deviation. Parametric tests were applied as data fitted a Gaussian 
distribution. The Mann–Whitney U test was used to compare 
mean BMI, blood pressure and glucose between groups with 
and without AN. Spearman’s rank correlations were utilised in 
order to compare continuous variables. A p-value of p  <  0.05 
was regarded to be statistically significant in hypothesis testing.
Results
Demographics of the total study population
A total of 390 females of mixed ancestry were recruited. They had a 
mean age of 49.1 years (range 30 years to 70 years) with a mean BMI 
of 31.7 kg/m2 (range 16.4–61.1 kg/m2). The mean systolic and diastolic 
Table 1: Grading of severity of acanthosis nigricans in the neck and axillae
Grade AN in the neck AN in the axillae
0 Absent Absent
1 Clearly present on close visual inspection but extent 
not measurable
Clearly present on close inspection, extent not 
measurable
2 Limited to the base of the skull and not extending to 
the lateral margins of the neck
Mild, located to central portion of the axilla
3 Extending to the lateral margins of the neck, but not 
visible from the front
Moderate, involving entire axillary fossa, but not visi-
ble when the arm is against the participant’s side
4 Extending anteriorly and visible from the front Severe; visible from the front or the back in the 
unclothed participant when the arm is against the 
participant’s side
Table 2: Clinical characteristics of individuals with and without acanthosis nigricans
Individuals with AN Individuals without AN Significance
Mean age (years) 46.9 50 p = 0.005
Mean BMI (kg/m2) 37.2 29.4 p < 0.001
Random blood glucose (mmol/l) 7.4 6.7 p = 0.04
Mean systolic BP (mmHg) 142.8 143.0 p = 0.96
Mean diastolic BP (mmHg) 94.3 92.9 p = 0.31
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blood pressure was 143 mmHg (range 71–235 mmHg) and 93 mmHg 
(range 46–134  mmHg) respectively. The mean random blood 
glucose for the group was 6.9 mmol/l (3.3–25.6 mmol/l). Of the total 
study population, 18% (n = 70) had diabetes mellitus (55 known and 
15 newly diagnosed in the study).
Prevalence and distribution of AN
AN was observed in 30% (n = 116) of participants. The most 
common site for AN was the neck (94%; n = 109), followed by the 
axillae (45%; n = 52), with 39% (n = 45) of these having AN in both 
the neck and axillae. AN on the elbows (n = 1), knuckles (n = 3) 
and knees (n = 0) was rarely seen. These three cases had severe 
AN (present in the neck and axillae, grade 3 and 4) and were 
obese (BMI 32, 42 and 44  kg/m2 respectively), with poorly 
controlled type 2 diabetics. Two of the three had a strong family 
history of diabetes with two first-degree relatives affected.
Characteristics of subjects with AN
Significant differences in subjects with and without AN are 
summarised in Table 2.
Participants with AN were younger and of higher body mass with a 
higher random blood glucose. Similar blood pressures were 
observed and AN was not more common in hypertensive compared 
with normotensive participants (30.58% vs. 27.03%; p = 0.49).
AN was associated with a family history of AN (p = 0.002), with the 
mother reported as the most common first-degree relative. AN 
was not associated with a family history of diabetes (p = 0.11) or 
cancer (p  = 0.86).
Association of AN with blood glucose and type 2 
diabetes mellitus
Individuals with AN had a significantly higher mean random blood 
glucose (7.4 mmol/l vs. 6.7 mmol/l; p  = 0.04) and were more com-
monly known to have a history of diabetes (20% vs. 11%).
AN was also more commonly seen in diabetics (old and newly 
diagnosed) vs. non-diabetics (47.1% vs. 25.9%; p = 0.004). However, 
neither a history of diabetes, nor treatment with insulin, was 
associated with more severe AN (p = 0.19 and p = 0.26 respectively).
When treated diabetics (n = 55) were excluded, HGT corrected for 
BMI was associated with AN overall (p < 0.001), AN in the neck (p < 
0.001) and AN in the axillae (p < 0.001). On dividing HGT into tertiles 
(Figure 1), an increase in the prevalence of AN was observed with 
higher glucose values (tertile 1, 20%; tertile 2, 30%; tertile 3, 39%) 
with individuals with HGT levels in the upper tertile being twice as 
likely to develop AN overall compared with the lower tertile (OR 
2.299).
Association of AN with body mass index
A linear increase in the prevalence of AN was seen in increasing 
weight categories (p < 0.001), with 2.44% of underweight/normal 
weight individuals having AN, compared with 13.98% in the 
overweight group and 46.98% in the obese group (Figure 2). A similar 
increase was seen in the obese subcategories (35.11%, 47.62% and 
65.52% for obese class I, II and III respectively). This association was 
observed for AN in both the neck (p < 0.001) and axillae (p < 0.001).
The severity of AN in the neck, as judged by the Burke scale, 
strongly correlated with BMI (p < 0.001), with more severe AN 
seen in higher weight categories (p = 0.010). The grade or severity 
of AN in the axilla was not associated with BMI (p = 0.85) or weight 
category (p = 0.61).
When adjusting for glucose, the odds of developing AN at any site 
still increased with increasing weight categories when compared 
with normal-weight individuals. Overweight individuals were 6 
times more likely to have AN, while obese individuals were 22 
times, 37 times and 74 times more likely if in obese class I, II and III 
respectively. Similarly, increasing odds of developing AN in the 
neck were observed with increasing weight categories. Increasing 
odds of developing AN in the axillae were not seen with increasing 
BMI.
Discussion
The American Diabetes Association (ADA) recognises AN as a risk 
factor for T2DM and for this reason it has been included in risk 
assessment protocols since 2000. They recommend testing to 
detect T2DM and prediabetes in asymptomatic adults of any age 
who have a BMI of ≥ 25 kg/m2 and who have one or more additional 
risk factor(s), with AN seen as a marker of insulin resistance.10
The ethnic variability of AN has been well described, with darker 
pigmented groups being most commonly affected. Prevalence 
rates vary from  <  1% in whites to up to 34.2% in Cherokee 
patients,11 creating the need to confirm its use as a screening tool 
in specific population groups.10 Since it was our clinical impression 
that AN is too common in our mixed-ancestry population to point 
to underlying insulin resistance, this benign hyperplastic lesion 
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Figure 2: The prevalence of AN in increasing weight categories.
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blood glucose levels and obesity. It is not associated with higher 
blood pressures and hypertension. The presence and severity of 
AN in the neck correlates best with glucose levels and BMI and is 
the site of choice when evaluating our mixed-ancestry population. 
AN is more common in diabetics, but is not limited to this group, 
strengthening its role as a screening tool. The significance of the 
presence and degree of AN in T2DM and its association with 
micro- and macrovascular damage needs to be investigated 
further.
Our study had several strengths. A single observer evaluated 
participants and where the classification of AN was difficult a 
specialist dermatologist was consulted. AN was also observed in 
an unselected female mixed-ancestry group and sub-analysis in 
diabetics and obese individuals was only performed at the end, 
preventing observer bias. Our study also had several limitations, 
one being that fasting glucose and insulin levels were not 
determined and associations with insulin resistance can therefore 
not be confirmed. In addition AN was not evaluated in other 
ethnic groups.
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We found AN to be extremely common, with a prevalence of 30% 
in this female group of mixed ancestry. We also demonstrated a 
clear association with blood glucose levels, diabetes and obesity, 
proving that it is not just a normal ethnic phenomenon. We found 
no association with blood pressure or hypertension.
The prevalence rate found in our study group ranks amongst the 
highest in the world. Other similar high rates were seen amongst 
260 Native Americans of the Alabama-Coushatta tribe, Texas 
(prevalence of 38%)9 and 2 205 Cherokee Indians (prevalence 
34.2%),8 where AN was associated with hyperinsulinaemia. A lower 
prevalence was seen in New Mexico (21%)4 and Sri Lanka (17.4%),12 
while still associated with diabetes or impaired glucose tolerance.
The association of AN with higher random glucose levels and 
diabetes was also apparent in our study. Those with AN had higher 
glucose levels than those without, and diabetics were twice as likely 
to have AN compared with non-diabetics. In non-diabetics, AN was 
more commonly seen with higher glucose levels, establishing AN as 
a risk factor for T2DM and thus a screening tool in this group. The 
association with blood glucose was independent of bodyweight, a 
finding supported in the literature.11
AN was seen in nearly half (47%) of the diabetics in our study, similar 
to figures quoted from the Caribbean (52.7%),10 New Mexico (47%)4 
and Texas (41.1%).2 In the literature, a wide prevalence range is 
reported amongst T2DM patients, ranging from 17% in Nigeria13 to 
73.3% in Cherokee Indians.8 Stuart et al. suggested large differences 
in the insulin sensitivity of the potentially affected skin areas amongst 
ethnic groups.14
In our study population, AN was extremely common in obese 
individuals, with a prevalence of 46.98% compared with only 2.44% 
in underweight/normal weight individuals. A linear increase in 
prevalence with increasing weight category could be demonstrated, 
together with more extensive AN with higher weight categories. This 
association was independent of blood glucose levels. The presence 
of AN with obesity, and the disappearance thereof with weight loss, 
is well documented.2,14
The nape of the neck was the most commonly affected site in our 
subjects (94%), which is in keeping with findings in studies 
performed on Indian (93.5%)1 and Mexican American populations 
(93%).2 We also found that the presence and severity of AN in the 
neck correlated best with BMI and blood glucose when compared 
with other sites. We therefore support the suggestion by Burke et 
al.2 that only the neck needs to be inspected in epidemiological 
studies and in our opinion in clinical practice.
An interesting finding was that known diabetics, and those on insulin 
treatment (presumed to have more severe diabetes) did not have 
more severe AN, a possible reflection of decreased endogenous 
insulin in these groups. The significance of the degree of AN in 
diabetics therefore needs to be investigated further.
Currently more than 50% of diabetic patients remain undiagnosed,10 
a reality also in our Western Cape communities.15 Our study clearly 
showed that AN has an important role in the detection of obesity-
mediated insulin resistance and can therefore be used in the 
screening process for T2DM. The ADA recommendation that a 
screening process of testing obese individuals with AN should 
therefore be followed.
In summary, our study found that AN is common in our mixed-
ancestry population, and is independently associated with higher 
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